Wall Street brokerages predict that Encompass Health Corp (NYSE:EHC) will post $1.11 billion in sales for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Encompass Health’s earnings. The highest sales estimate is $1.13 billion and the lowest is $1.10 billion. Encompass Health reported sales of $1.05 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 5.7%. The firm is expected to issue its next earnings results on Thursday, April 25th.
On average, analysts expect that Encompass Health will report full year sales of $4.53 billion for the current financial year, with estimates ranging from $4.51 billion to $4.56 billion. For the next financial year, analysts expect that the company will post sales of $4.75 billion, with estimates ranging from $4.68 billion to $4.80 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Encompass Health.
A number of equities analysts have issued reports on EHC shares. Jefferies Financial Group started coverage on shares of Encompass Health in a research note on Thursday, December 20th. They issued a “buy” rating on the stock. Barclays started coverage on shares of Encompass Health in a research note on Friday, December 14th. They issued an “equal weight” rating and a $75.00 price objective on the stock. UBS Group started coverage on shares of Encompass Health in a research note on Thursday, November 15th. They issued a “buy” rating and a $86.00 price objective on the stock. Finally, ValuEngine raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $74.88.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: Cost of Capital Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.